Research Output per year
Fingerprint Dive into the research topics where I. Láng is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 13 Similar Profiles
Breast Neoplasms
Medicine & Life Sciences
letrozole
Medicine & Life Sciences
Lymphocytes
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Antibody-Dependent Cell Cytotoxicity
Medicine & Life Sciences
Disease-Free Survival
Medicine & Life Sciences
Silymarin
Medicine & Life Sciences
Antibodies
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 1973 2019
12
Citations
(Scopus)
Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients
Lambertini, M., Campbell, C., Bines, J., Korde, L. A., Izquierdo, M., Fumagalli, D., Del Mastro, L., Ignatiadis, M., Pritchard, K., Wolff, A. C., Jackisch, C., Láng, I., Untch, M., Smith, I., Boyle, F., Xu, B., Barrios, C. H., Baselga, J., Moreno-Aspitia, A., Piccart, M. & 2 others, , jan. 1 2019, In : Journal of the National Cancer Institute. 111, 1, p. 86-94 9 p.Research output: Article
Amenorrhea
Breast Neoplasms
Survival
Hormones
Therapeutics
Survival outcomes of the NeoALTTO study (BIG 1–06): updated results of a randomised multicenter phase III neoadjuvant clinical trial in patients with HER2-positive primary breast cancer
Huober, J., Holmes, E., Baselga, J., de Azambuja, E., Untch, M., Fumagalli, D., Sarp, S., Láng, I., Smith, I., Boyle, F., Xu, B., Lecocq, C., Wildiers, H., Jouannaud, C., Hackman, J., Dasappa, L., Ciruelos, E., Toral Pena, J. C., Adamchuk, H., Hickish, T. & 5 others, , szept. 1 2019, In : European Journal of Cancer. 118, p. 169-177 9 p.Research output: Article
Phase III Clinical Trials
Disease-Free Survival
Outcome Assessment (Health Care)
Breast Neoplasms
Survival
21
Citations
(Scopus)
Efficacy of chemotherapy for ER-negative and ER-positive isolated locoregional recurrence of breast cancer: Final analysis of the CALOR trial
Wapnir, I. L., Price, K. N., Anderson, S. J., Robidoux, A., Martín, M., Nortier, J. W. R., Paterson, A. H. G., Rimawi, M. F., Láng, I., Baena-Cañada, J. M., Thürlimann, B., Mamounas, E. P., Geyer, C. E., Gelber, S., Coates, A. S., Gelber, R. D., Rastogi, P., Regan, M. M., Wolmark, N. & Aebi, S., ápr. 10 2018, In : Journal of Clinical Oncology. 36, 11, p. 1073-1079 7 p.Research output: Article
Estrogen Receptors
Breast Neoplasms
Recurrence
Drug Therapy
Disease-Free Survival